Synthaverse Balance Sheet Health
Financial Health criteria checks 2/6
Synthaverse has a total shareholder equity of PLN112.6M and total debt of PLN66.8M, which brings its debt-to-equity ratio to 59.3%. Its total assets and total liabilities are PLN265.9M and PLN153.3M respectively. Synthaverse's EBIT is PLN8.4M making its interest coverage ratio 7. It has cash and short-term investments of PLN2.2M.
Key information
59.3%
Debt to equity ratio
zł66.78m
Debt
| Interest coverage ratio | 7x |
| Cash | zł2.18m |
| Equity | zł112.64m |
| Total liabilities | zł153.26m |
| Total assets | zł265.90m |
Recent financial health updates
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Seems To Use Debt Quite Sensibly
Oct 14
Is BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) A Risky Investment?
Mar 08BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Takes On Some Risk With Its Use Of Debt
Dec 07
Recent updates
Optimistic Investors Push Synthaverse S.A. (WSE:SVE) Shares Up 32% But Growth Is Lacking
Apr 20Why Synthaverse's (WSE:SVE) Soft Earnings Are Just The Beginning Of Its Problems
Apr 18BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Seems To Use Debt Quite Sensibly
Oct 14More Unpleasant Surprises Could Be In Store For BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.'s (WSE:BML) Shares After Tumbling 48%
Nov 29We Think You Should Be Aware Of Some Concerning Factors In BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek's (WSE:BML) Earnings
Nov 16Does BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Deserve A Spot On Your Watchlist?
May 02Is BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) A Risky Investment?
Mar 08What Percentage Of BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. (WSE:BML) Shares Do Insiders Own?
Jan 29Should Weakness in BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A.'s (WSE:BML) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 03BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek (WSE:BML) Takes On Some Risk With Its Use Of Debt
Dec 07Financial Position Analysis
Short Term Liabilities: SVE's short term assets (PLN45.6M) exceed its short term liabilities (PLN31.0M).
Long Term Liabilities: SVE's short term assets (PLN45.6M) do not cover its long term liabilities (PLN122.3M).
Debt to Equity History and Analysis
Debt Level: SVE's net debt to equity ratio (57.4%) is considered high.
Reducing Debt: SVE's debt to equity ratio has increased from 31.5% to 59.3% over the past 5 years.
Debt Coverage: SVE's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: SVE's interest payments on its debt are well covered by EBIT (7x coverage).